KRN 7000: Clinical Trials

5 trials of KRN 7000, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Recruiting 1
Phase 13Completed 3

Follow KRN 7000: new trials by email Literature Review of KRN 7000 trials Research Report on KRN 7000

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
BPC-2001 - Graft -Versus-host-disease, aGVHD
Phase 2RecruitingBioPhoenix Co., Ltd.502025-10-292026-08-17
RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation
RGI-2001, Standard of Care - Graft Vs Host Disease, Graft-versus-host-disease
Phase 2CompletedRegimmune Corporation492019-11-252024-05-28
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
RGI-2001, Calcineurin Inhibitors, Allogeneic Hematopoietic Stem Cell Transplantation - Graft Versus Host Disease
Phase 1 / Phase 2CompletedRegimmune Corporation682011-09-012019-10-23
Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection
KRN7000 - Chronic Hepatitis C
Phase 1 / Phase 2CompletedFoundation for Liver Research362003-08-012006-07-14
KRN7000 in Chronic Hepatitis B
KRN7000 - Hepatitis B, Chronic
Phase 1 / Phase 2CompletedFoundation for Liver Research282003-03-012006-08-15

Conditions studied

Graft vs Host Disease (3)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Hematologic Neoplasms (1)  ·  Hepatitis B (1)  ·  Hepatitis B, Chronic (1)  ·  Hepatitis C, Chronic (1)  ·  Leukemia (1)  ·  Myelodysplastic Syndromes (1)

Sponsors

Foundation for Liver Research (2)  ·  Regimmune Corporation (2)  ·  BioPhoenix Co., Ltd. (1)

Countries

Netherlands (2)  ·  United States (2)  ·  China (1)

Top investigators

Carin MJ van Nieuwkerk, MD, PhD (1)  ·  Xiaodong Mo, PhD (1)  ·  Yi-Bin Chen, MD (1)

Results publications

PMID 40680268